2m 2m 2m 2m 2m 2m 2m
GENELUX (GNLX)
NASDAQ
$1.97-$0.10 (-5.07%)
Price as of Oct 22, 2026 7:30 PM EDT- $93.7MMarket Cap
- -67.19%1-Year Change
- BiotechnologyIndustry
GENELUX (GNLX)
$1.97-$0.10 (-5.07%)
GNLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.07 | ||
Change | -$0.43 (-17.20%) | ||
Open | $2.53 | ||
High | $2.57 | ||
Low | $2.02 | ||
Previous Close | $2.50 | ||
Volume | 850,545 | ||
30-Day Average Volume | 268,035 | ||
1-Week Change | -10.78% | ||
1-Month Change | -19.14% | ||
1-Year Change | -67.19% | ||
3-Year Change | -89.72% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.2M | ||
Total Assets | $26.2M | ||
Market Cap | $93.7M | ||
Enterprise Value | $84.5M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$9.5M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $11.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 28,158 | ||
P/B | 6 | ||
P/E | -10 | ||
PEG | 2 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue